NK/T-CELL LYMPHOMA
Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lymphomas: experimental drug GNC-038 enters human testing
Disease control OngoingThis early-phase study tests an experimental drug called GNC-038 in people with certain lymphomas (NK/T-cell lymphoma, AITL, and other non-Hodgkin lymphomas) that have returned or not responded to standard therapy. The main goals are to check the drug's safety, find the best dose…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New blood test could revolutionize lymphoma monitoring
Knowledge-focused OngoingThis study looks at whether a new blood test can find tiny bits of tumor DNA in people with T-cell lymphoma. The goal is to see if this test can help doctors track how well treatment is working and predict if the cancer might come back. About 50 adults with newly diagnosed or ret…
Matched conditions: NK/T-CELL LYMPHOMA
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC